Auricular Acupressure for Premenstrual Syndrome in Female Students

Premenstrual Syndrome (PMS) is a common gynecological disorder that significantly affects the quality of life for women of reproductive age, with symptoms including emotional, behavioral, and physical disturbances occurring approximately one week before menstruation. PMS is especially prevalent among female undergraduate students, who often experience heightened stress due to academic pressures and lack emotional coping strategies. While pharmacological treatments, such as SSRIs and hormonal therapies, have been used to manage PMS symptoms, they may have side effects and are not always effective in the long term. This has led to increasing interest in alternative treatments such as traditional medicine. Auricular acupressure, a non-invasive and low-risk method, has shown promising results in managing PMS symptoms and is gaining attention as a possible solution. The goal of this clinical trial is to evaluate the efficacy and safety of auricular acupressure in reducing PMS symptoms in female undergraduate students. The main questions it aims to answer are: * Does auricular acupressure reduce the severity of PMS symptoms in female undergraduate students? * Is auricular acupressure safe and well-tolerated by participants? Researchers will compare the intervention group (receiving auricular acupressure) to the control group (receiving sham auricular acupressure) to see if auricular acupressure has a significant impact on reducing PMS symptoms and improving quality of life. Participants will: * Receive auricular acupressure on specific acupoints or sham treatment. * Complete assessments of PMS symptoms using the Premenstrual Symptoms Screening Tool (PSST) at baseline, 1 week, and 8 weeks. * Complete a quality of life assessment using the WHOQOL-Bref scale at the same time points. * Be monitored for any adverse effects during the 8-week trial period.

NCT Number	NCT06981533
Lead Sponsor	University of Medicine and Pharmacy at Ho Chi Minh City
Conditions	Premenstrual Syndrome
Enrollment	66 participants
Start Date	2025-04-20
Primary Completion	2025-09-30 (estimated)
Study Completion	2025-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-09